2012-09-17T15:06:29-05:00 2011-12-31 161600045 SZYMKOWIAK & ASSOCIATES CPAS PC 333 INTERNATIONAL DRIVE SUITE A-2 WILLIAMSVILLE NY 14221 990EZ 2011-01-01 263085485 THE JACOBS INSTITUTE INC JACO 7168538671 875 ELLICOTT STREET 5TH FLOOR BUFFALO NY 14203 DANIEL J ZIMMER 7168585208 2012-09-17 1 STEVEN G AUSTIN P00182318 7166262626 2011 2016-02-24 21:20:13Z X X N/A X 31000 X 31000 31000 31019 4157 35176 -4176 -10005 0 -14181 X 8710 8499 8710 8499 18715 22680 -10005 -14181 X THE JACOBS INSTITUTE, A NEW YORK NOT-FOR-PROFIT CORPORATION ORGANIZED EXCLUSIVELY FOR CHARITABLE, EDUCATIONAL AND SCIENTIFIC PURPOSES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, WAS FORMED TO ACCOMPLISH THE LATE DR. LAWRENCE D. JACOBS, M.D.'S VISION BY MAKING WESTERN NEW YORK A CENTER FOR WORLD CLASS EXCELLENCE IN RESEARCH, TEACHING, PUBLIC AWARENESS AND ADVANCES IN CLINICAL AND MINIMALLY INVASIVE SURGICAL TREATMENT OF GLOBAL VASCULAR DISEASE (CONDITIONS THAT AFFECT THE BLOOD VESSELS, ARTERIES AND VEINS) AND RELATED NEUROLOGICAL DISEASES, SUCH AS MULTIPLE SCLEROSIS ("MS").IN ORDER TO ACCOMPLISH THIS PURPOSE, THE JACOBS INSTITUTE WILL UNDERTAKE THE FOLLOWING ACTIVITIES FOR THE PUBLIC GOOD IN ADVANCEMENT OF ITS TAX EXEMPT PURPOSES: INVESTIGATION AND DUE DILIGENCE RELATED TO IMPLEMENTATION OF ALL ACTIVITIES ON SCHEDULE O 0 35176 35176 THOMAS R BEECHER JR 120 W TUPPER BUFFALO NY 14201 1.00 0 0 0 L NELSON HOPKINS III 875 ELLICOTT STREET BUFFALO NY 14203 20.00 0 0 0 LUKE T JACOBS 120 W TUPPER BUFFALO NY 14201 1.00 0 0 0 WILLIAM P GRESSER JR 120 W TUPPER BUFFALO NY 14201 1.00 0 0 0 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NY EDWARD P SCHNEIDER FLINT SERVICE CENTER ROADS AMHERST NY 14260 7166453011 0 0 0 0 0 0 0 0 0 0 NONE NONE 1 X 305000 429500 31000 765500 305000 429500 31000 765500 703880 61620 765500 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED OTHER EXPENSES FORM 990-EZ, PART I, LINE 16 DESCRIPTION: PROGRAM RELATED EXPENSES. AMOUNT: 4,157. OTHER LIABILITIES FORM 990-EZ, PART II, LINE 26 DESCRIPTION: ACCOUNTS PAYABLE. BEG. OF YEAR AMOUNT: 18,715. END OF YEAR AMOUNT: 22,680. RESEARCH/ADVANCEMENTS-PROVIDE STAFFING AND RESEARCH SUPPORT TO ACADEMICS, RESEARCHERS AND CLINICIANS AT: (1) THE STATE UNIVERSITY OF NEW YORK, UNIVERSITY AT BUFFALO ("UNIVERSITY AT BUFFALO"), A 501(C)(3) ORGANIZATION; (2) KALEIDA HEALTH (THE LARGEST HOSPITAL NETWORK IN WESTERN NEW YORK), A 501(C)(3) ORGANIZATION; AND (3) OTHER SIMILAR HEALTH-RELATED 501(C)(3) ORGANIZATIONS SELECTED BY THE MANAGEMENT OF THE JACOBS INSTITUTE; IN ORDER TO FACILITATE THE DEVELOPMENT BY SUCH ORGANIZATIONS OF: (A) ADVANCEMENTS IN THE TREATMENT OF GLOBAL VASCULAR DISEASE AND RELATED NEUROLOGICAL DISEASE; AND (B) CUTTING EDGE TECHNOLOGIES AND OTHER INNOVATIONS FOR THE IMPROVEMENT OF SUCH TREATMENT. TEACHING - ATTRACT, RECRUIT AND RETAIN WORLD CLASS CLINICAL, RESEARCH AND ACADEMIC EXPERTS IN THE AREA OF GLOBAL VASCULAR DISEASE AND RELATED NEUROLOGICAL DISEASES TO WESTERN NEW YORK: (1) TO BROADEN THE DEPTH OF TEACHING AT THE UNIVERSITY AT BUFFALO SCHOOL OF MEDICINE AND BIOMEDICAL SCIENCES ("SCHOOL OF MEDICINE") AND MAY, AMONG OTHER THINGS, CREATE ONE OR MORE TEACHING AND/OR ACADEMIC RESEARCH POSITIONS AT THE SCHOOL OF MEDICINE OR OTHER 501(C)(3) INSTITUTION; AND (2) TO ESTABLISH WESTERN NEW YORK AS THE PRIMARY LOCATION FOR ACADEMIC COLLABORATION IN THE TREATMENT OF GLOBAL VASCULAR DISEASE AND RELATED NEUROLOGICAL DISEASES. PUBLIC AWARENESS - SPONSOR AND COORDINATE PUBLIC HEALTH INITIATIVES RAISING AWARENESS ABOUT VASCULAR DISEASE AND THE NEED FOR IMPROVED TREATMENT OF SUCH DISEASES. PROOF OF CONCEPT OF INNOVATIONS - VET INNOVATIONS IN CLINICAL CARE, ACADEMICS AND RESEARCH, RESULTING IN THE DEVELOPMENT OF NEW RESEARCH, CLINICAL CARE AND SPIN OFF ENTREPRENEURIAL DEVELOPMENTS AND JOBS IN WESTERN NEW YORK. BY CONDUCTING THE FOREGOING ACTIVITIES, THE JACOBS INSTITUTE HOPES TO CREATE "COLLISIONS" OF IDEAS BETWEEN ACADEMICS, RESEARCHERS AND CLINICIANS TO PROMOTE CLINICAL CARE, ACADEMIC, RESEARCH AND ENTREPRENEURIAL ("CARE") EXCELLENCE IN THE TREATMENT OF GLOBAL VASCULAR DISEASE AND RELATED NEUROLOGICAL DISEASES WITH THE ULTIMATE GOAL THAT THESE "COLLISIONS" WILL LEAD TO IMPROVED TREATMENT OF, AND NEW AND IMPROVED TECHNOLOGY AND INNOVATIONS RELATED TO, GLOBAL VASCULAR DISEASE AND RELATED NEUROLOGICAL DISEASES THAT MAY NOT OTHERWISE ATTRACT SUFFICIENT FUNDING IN WESTERN NEW YORK. THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.